Cargando…
Senescence program and its reprogramming in pancreatic premalignancy
Tumor is a representative of cell immortalization, while senescence irreversibly arrests cell proliferation. Although tumorigenesis and senescence seem contrary to each other, they have similar mechanisms in many aspects. Pancreatic ductal adenocarcinoma (PDA) is highly lethal disease, which occurs...
Autores principales: | Yang, Kailing, Li, Xiaojia, Xie, Keping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435572/ https://www.ncbi.nlm.nih.gov/pubmed/37591827 http://dx.doi.org/10.1038/s41419-023-06040-3 |
Ejemplares similares
-
Epigenetic reprogramming in pancreatic premalignancy and clinical implications
por: Zhang, Wei, et al.
Publicado: (2023) -
Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells
por: Suzuki, Tatsunori, et al.
Publicado: (2021) -
Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions
por: Kolodkin-Gal, Dror, et al.
Publicado: (2022) -
Advances in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Premalignant Pancreatic Lesions
por: Yamada, Reiko, et al.
Publicado: (2023) -
Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
por: Cruz, Mart Dela, et al.
Publicado: (2017)